Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Downing

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Nature Communications|June 20, 2018
The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrowLijian Shao, Jianhui Chang, Wei Feng, et al.
Journal of Pharmaceutical Sciences|December 17, 2020
The Inclusion of a Matrix Metalloproteinase-9 Responsive Sequence in Self-assembled Peptide-based Brain-Targeting Nanoparticles Improves the Efficiency of Nanoparticles Crossing the Blood-Brain Barrier at Elevated MMP-9 LevelsYamir Islam, Parinaz Ehtezazi, Andrew Cashmore, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Plos One|January 28, 2014
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathwaysStephen Smith, Rati Tripathi, Charnise Goodings, et al.
Nature|August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumoursElizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pharmacogenomics|September 13, 2013
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsXueyuan Cao, Amit K Mitra, Stanley Pounds, et al.
Nature Communications|June 20, 2018
The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrowLijian Shao, Jianhui Chang, Wei Feng, et al.
Journal of Pharmaceutical Sciences|December 17, 2020
The Inclusion of a Matrix Metalloproteinase-9 Responsive Sequence in Self-assembled Peptide-based Brain-Targeting Nanoparticles Improves the Efficiency of Nanoparticles Crossing the Blood-Brain Barrier at Elevated MMP-9 LevelsYamir Islam, Parinaz Ehtezazi, Andrew Cashmore, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2011
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemiaAmit K Mitra, Kristine R Crews, Stanley Pounds, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Plos One|January 28, 2014
LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathwaysStephen Smith, Rati Tripathi, Charnise Goodings, et al.
Nature|August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumoursElizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Pageof 3